---
title: "BH_NonClinical_Pharmacy_Car-T"
ocid: "ocds-h6vhtk-05e8d3"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05e8d3"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-05e8d3.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-05e8d3.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "BARTS HEALTH NHS TRUST"
published: "2025-11-26"
---

# BH_NonClinical_Pharmacy_Car-T

Buyer: BARTS HEALTH NHS TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-05e8d3

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05e8d3)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-05e8d3.json)

## Summary

Barts Health NHS Trust, located in London, has completed a procurement process for the provision of CAR-T therapy products, a cutting-edge personalised immunotherapy treatment to fight cancer. The contract is under the industry category of medical equipment, pharmaceuticals, and pharmacy services, and it was directly awarded to Bristol Myers Squibb due to their unique capabilities in this area. The contract, which has a start date of 8th December 2025, will have an initial duration of five years with an option to extend for an additional five years. There are no minimum order commitments, and prices are capped at those approved by NICE/NHS England.

This tender presents substantial business growth opportunities, especially for enterprises specialising in medical innovations and pharmaceuticals. Large suppliers with capacity to provide sophisticated medical treatments like CAR-T therapy may find this contract with the public healthcare sector advantageous in establishing long-term partnerships. Given the exclusive supplier arrangements owing to the intellectual property considerations, businesses possessing similar exclusive capabilities can leverage such procurement opportunities to expand their footprint within the UK's healthcare market.

## Notice

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.

### Procurement Information

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells. The products can only be supplied by the the proposed contractor, Bristol Myers Squibb.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/077086-2025 |
| Notice type | UK5 - Transparency Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 26 Nov 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 26 Nov 2025 |
| Contract period | 8 Dec 2025 - 5 Dec 2030 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £2,100,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Pending |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BARTS HEALTH NHS TRUST |
| Locality | LONDON |
| Post town | East London |
| Postcode | E14 5HJ |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Blackwall & Cubitt Town |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | BRISTOL MYERS SQUIBB |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products
- 85 - Health and social work services

### Codes

- 33000000 - Medical equipments, pharmaceuticals and personal care products
- 85149000 - Pharmacy services

## Release History

- 26 Nov 2025 at 09:46 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/077086-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/077086-2025
  26th November 2025 - Transparency notice on Find a Tender

## Notice URLs

- https://www.bartshealth.nhs.uk
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05e8d3. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-05e8d3.json.